Anemia of chronic disease: A unique defect of iron recycling for many different chronic diseases

European Journal of Internal Medicine

Volumn 25, Issue 1, 2014, Pages 12-17

  Poggiali, Erika ^a   Migone De Amicis, Margherita ^a   Motta, Irene ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Anemia; Chronic disease; Hepcidin; Inflammation; Iron metabolism

Indexed keywords

ANTIANEMIC AGENT; CYTOKINE; FERRITIN; GAMMA INTERFERON; HEPCIDIN; INTERLEUKIN 1; INTERLEUKIN 6; IRON; IRON DERIVATIVE; REACTIVE OXYGEN METABOLITE; RECOMBINANT ERYTHROPOIETIN; STAT3 PROTEIN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANEMIA OF CHRONIC DISEASE; BLEEDING; BLOOD TRANSFUSION; CELL PROLIFERATION; CHRONIC DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; ERYTHROCYTE LIFESPAN; ERYTHROID PRECURSOR CELL; HEMOLYSIS; HUMAN; INFLAMMATION; IRON METABOLISM; MACROPHAGE; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RETICULOENDOTHELIAL SYSTEM; REVIEW; SYMPTOMATOLOGY; TREATMENT INDICATION; UPREGULATION; VITAMIN DEFICIENCY;

ANEMIA; CHRONIC DISEASE; HEPCIDIN; INFLAMMATION; IRON METABOLISM;

ANEMIA; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC DISEASE; CYTOKINES; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; HEPCIDINS; HUMANS; INFLAMMATION; IRON; UP-REGULATION;

EID: 84892831241     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.07.011     Document Type: Review

References (94)

1. G. Weiss, and L.T. Goodnough Anemia of chronic disease N Engl J Med 352 2005 1011 1023
2. G.E. Cartwright The anemia of chronic disorders Semin Hematol 3 1966 351 375
3. I. Theurl, V. Mattle, M. Seifert, M. Mariani, C. Marth, and G. Weiss Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease Blood 107 2006 4142 4148
4. Y. Matzner, S. Levy, N. Grossowicz, G. Izak, and C. Hershko Prevalence and causes of anemia in elderly hospitalized patients Gerontology 25 1979 113 119
5. G. Weiss Pathogenesis and treatment of anaemia of chronic disease Blood Rev 16 2002 87 96
6. R.T. Means Jr. Recent developments in the anemia of chronic disease Curr Hematol Rep 2 2003 116 121
7. B.F. Culleton, B.J. Manns, J. Zhang, M. Tonelli, S. Klarenbach, and B.R. Hemmelgarn Impact of anemia on hospitalization and mortality in older adults Blood 107 2006 3841 3846
8. J.M. Guralnik, R.S. Eisenstaedt, L. Ferrucci, H.G. Klein, and R.C. Woodman Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia Blood 104 2004 2263 2268
9. R. Woodman, L. Ferrucci, and J. Guralnik Anemia in older adults Curr Opin Hematol 12 2005 123 128
10. CDC National Health Nutrition Examination Survey, Anthropometric Reference Data. United States Available from: http://www.cdc.gov/nchs/nhanes.htm 1988-1994 [Accessed on 8 July 2013]
11. E.R. Stadtman Protein oxidation in aging and age-related diseases Ann N Y Acad Sci 928 2001 22 38
12. E. Riva, M. Tettamanti, P. Mosconi, G. Apolone, F. Gandini, and A. Nobili et al. Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study Haematologica 94 2009 22 28
13. K. Punnonen, K. Irjala, and A. Rajamaki Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency Blood 89 1997 1052 1057
14. G.E. Cartwright, and M. Wintrobe The anemia of infection-a review Advances in Internal Medicine W. Dock, I. Snapper, 5 1952 The Year Book Publisher Chicago 165 226
15. E. Nemeth, E.V. Valore, M. Territo, G. Schiller, A. Lichtenstein, and T. Ganz Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein Blood 101 2003 2461 2463
16. K.A. Ahmad, J.R. Ahmann, M.C. Migas, A. Waheed, R.S. Britton, and B.R. Bacon et al. Decreased liver hepcidin expression in the Hfe knockout mouse Blood Cells Mol Dis 29 2002 361 366
17. G. Nicolas, M. Bennoun, A. Porteu, S. Mativet, C. Beaumont, and B. Grandchamp et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin Proc Natl Acad Sci U S A 99 2002 4596 4601
18. H.R. Peeters, M. Jongen-Lavrencic, A.N. Raja, H.S. Ramdin, G. Vreugdenhil, and F.C. Breedveld et al. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset Ann Rheum Dis 55 1996 162 168
19. A. Wilson, H.T. Yu, L.T. Goodnough, and A.R. Nissenson Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature Am J Med 116 2004 50S 57S
20. M.C. Hochberg, C.M. Arnold, B.B. Hogans, and J.L. Spivak Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia Arthritis Rheum 31 1988 1318 1321
21. M. Cazzola, L. Ponchio, F. de Benedetti, A. Ravelli, V. Rosti, and Y. Beguin et al. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis Blood 87 1996 4824 4830
22. L. Ferrucci, R.D. Semba, J.M. Guralnik, W.B. Ershler, S. Bandinelli, and K.V. Patel et al. Proinflammatory state, hepcidin, and anemia in older persons Blood 115 2010 3810 3816
23. W.P. den Elzen, A.J. de Craen, E.T. Wiegerinck, R.G. Westendorp, D.W. Swinkels, and J. Gussekloo Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study Haematologica 98 2013 448 454
24. J.L. Spivak Iron and the anemia of chronic disease Oncology (Williston Park) 16 2002 25 33
25. L. Rice, C.P. Alfrey, T. Driscoll, C.E. Whitley, D.L. Hachey, and W. Suki Neocytolysis contributes to the anemia of renal disease Am J Kidney Dis 33 1999 59 62
26. H.P. Ward, B. Gordon, and J.C. Pickett Serum levels of erythropoietin in rheumatoid arthritis J Lab Clin Med 74 1969 93 97
27. C.B. Miller, R.J. Jones, S. Piantadosi, M.D. Abeloff, and J.L. Spivak Decreased erythropoietin response in patients with the anemia of cancer N Engl J Med 322 1990 1689 1692
28. W. Jelkmann Proinflammatory cytokines lowering erythropoietin production J Interferon Cytokine Res 18 1998 555 559
29. T. Ganz, and E. Nemeth Hepcidin and iron homeostasis Biochim Biophys Acta 2012 1823 1434 1443
30. J.P. Pinto, S. Ribeiro, H. Pontes, S. Thowfeequ, D. Tosh, and F. Carvalho et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha Blood 111 2008 5727 5733
31. R.T. Means Jr., and S.B. Krantz Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin Blood 78 1991 2564 2567
32. J.P. Maciejewski, C. Selleri, T. Sato, H.J. Cho, L.K. Keefer, and C.F. Nathan et al. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha J Clin Invest 96 1995 1085 1092
33. M.D. Knutson, M. Oukka, L.M. Koss, F. Aydemir, and M. Wessling-Resnick Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin Proc Natl Acad Sci U S A 102 2005 1324 1328
34. M.K. Doyle, M.U. Rahman, C. Han, J. Han, J. Giles, and C.O. Bingham III et al. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials Semin Arthritis Rheum 39 2009 123 131
35. H.A. Papadaki, H.D. Kritikos, V. Valatas, D.T. Boumpas, and G.D. Eliopoulos Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy Blood 100 2002 474 482
36. G. Schett, U. Firbas, W. Fureder, H. Hiesberger, S. Winkler, and D. Wachauer et al. Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus Rheumatology (Oxford) 40 2001 424 431
37. G. Dallalio, E. Law, and R.T. Means Jr. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations Blood 107 2006 2702 2704
38. A. Krause, S. Neitz, H.J. Magert, A. Schulz, W.G. Forssmann, and P. Schulz-Knappe et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity FEBS Lett 480 2000 147 150
39. C.H. Park, E.V. Valore, A.J. Waring, and T. Ganz Hepcidin, a urinary antimicrobial peptide synthesized in the liver J Biol Chem 276 2001 7806 7810
40. T. Ganz Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation Blood 102 2003 783 788
41. E. Nemeth, M.S. Tuttle, J. Powelson, M.B. Vaughn, A. Donovan, and D.M. Ward et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 306 2004 2090 2093
42. R.E. Fleming, and W.S. Sly Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease Proc Natl Acad Sci U S A 98 2001 8160 8162
43. E. Nemeth, S. Rivera, V. Gabayan, C. Keller, S. Taudorf, and B.K. Pedersen et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin J Clin Invest 113 2004 1271 1276
44. A.E. Armitage, L.A. Eddowes, U. Gileadi, S. Cole, N. Spottiswoode, and T.A. Selvakumar et al. Hepcidin regulation by innate immune and infectious stimuli Blood 118 2011 4129 4139
45. E. Kemna, P. Pickkers, E. Nemeth, H. van der Hoeven, and D. Swinkels Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS Blood 106 2005 1864 1866
46. T. Ganz Hepcidin and its role in regulating systemic iron metabolism Hematology Am Soc Hematol Educ Program 29-35 2006 507
47. M.V. Verga Falzacappa, M. Vujic Spasic, R. Kessler, J. Stolte, M.W. Hentze, and M.U. Muckenthaler STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation Blood 109 2007 353 358
48. D.A. Weinstein, C.N. Roy, M.D. Fleming, M.F. Loda, J.I. Wolfsdorf, and N.C. Andrews Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease Blood 100 2002 3776 3781
49. K. Maes, E. Nemeth, G.D. Roodman, A. Huston, F. Esteve, and C. Freytes et al. In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2 Blood 116 2010 3635 3644
50. S. Hohaus, G. Massini, M. Giachelia, B. Vannata, V. Bozzoli, and A. Cuccaro et al. Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin J Clin Oncol 28 2010 2538 2543
51. B.T. Ciccarelli, C.J. Patterson, Z.R. Hunter, C. Hanzis, L. Ioakimidis, and R. Manning et al. Hepcidin is produced by lymphoplasmacytic cells and is associated with anemia in Waldenstrom's macroglobulinemia Clin Lymphoma Myeloma Leuk 11 2011 160 163
52. J.W. Adamson The anemia of inflammation/malignancy: mechanisms and management Hematology Am Soc Hematol Educ Program 2008 159 165
53. C. Brugnara, and N. Mohandas Red cell indices in classification and treatment of anemias: from M.M. Wintrobes's original 1934 classification to the third millennium Curr Opin Hematol 20 2013 222 230
54. G. Bergamaschi, A. Di Sabatino, R. Albertini, S. Ardizzone, P. Biancheri, and E. Bonetti et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment Haematologica 95 2010 199 205
55. C. Hershko, A.V. Hoffbrand, D. Keret, M. Souroujon, I. Maschler, and Y. Monselise et al. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia Haematologica 90 2005 585 595
56. F.M. Torti, and S.V. Torti Regulation of ferritin genes and protein Blood 99 2002 3505 3516
57. J.O. Cullis Diagnosis and management of anaemia of chronic disease: current status Br J Haematol 154 2011 289 300
58. B.S. Skikne, K. Punnonen, P.H. Caldron, M.T. Bennett, M. Rehu, and G.H. Gasior et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index Am J Hematol 86 2011 923 927
59. G. Barosi Inadequate erythropoietin response to anemia: definition and clinical relevance Ann Hematol 68 1994 215 223
60. I. Theurl, E. Aigner, M. Theurl, M. Nairz, M. Seifert, and A. Schroll et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications Blood 113 2009 5277 5286
61. T. Ganz, G. Olbina, D. Girelli, E. Nemeth, and M. Westerman Immunoassay for human serum hepcidin Blood 112 2008 4292 4297
62. A. Castagna, N. Campostrini, F. Zaninotto, and D. Girelli Hepcidin assay in serum by SELDI-TOF-MS and other approaches J Proteomics 73 2010 527 536
63. T.S. Perlstein, R. Pande, N. Berliner, and G.J. Vanasse Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation Blood 117 2011 2800 2806
64. M. Rossini, S. Maddali Bongi, G. La Montagna, G. Minisola, N. Malavolta, and L. Bernini et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability Arthritis Res Ther 12 2010 R216
65. L.W. Moreland, S.W. Baumgartner, M.H. Schiff, E.A. Tindall, R.M. Fleischmann, and A.L. Weaver et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein N Engl J Med 337 1997 141 147
66. L.T. Goodnough Indications for red cell transfusion Vox Sang 83 2002 7 9
67. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target Am J Kidney Dis 50 2007 471 530
68. C. Gasche, T. Waldhoer, T. Feichtenschlager, C. Male, A. Mayer, and C. Mittermaier et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia Am J Gastroenterol 96 2001 2382 2387
69. D.R. Ashby, D.P. Gale, M. Busbridge, K.G. Murphy, N.D. Duncan, and T.D. Cairns et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease Kidney Int 75 2009 976 981
70. E.D. Weinberg Iron loading and disease surveillance Emerg Infect Dis 5 1999 346 352
71. L. Maynor, and D.F. Brophy Risk of infection with intravenous iron therapy Ann Pharmacother 41 2007 1476 1480
72. M.E. Canziani, S.T. Yumiya, E.B. Rangel, S.R. Manfredi, M.C. Neto, and S.A. Draibe Risk of bacterial infection in patients under intravenous iron therapy: dose versus length of treatment Artif Organs 25 2001 866 869
73. J. Kletzmayr, G. Sunder-Plassmann, and W.H. Horl High dose intravenous iron: a note of caution Nephrol Dial Transplant 17 2002 962 965
74. J.L. Sullivan Iron therapy and cardiovascular disease Kidney Int Suppl 69 1999 S135 S137
75. D.H. Henry, N.V. Dahl, M. Auerbach, S. Tchekmedyian, and L.R. Laufman Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy Oncologist 12 2007 231 242
76. M. Hedenus, G. Birgegard, P. Nasman, L. Ahlberg, T. Karlsson, and B. Lauri et al. Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study Leukemia 21 2007 627 632
77. T. Kapoian, N.B. O'Mara, A.K. Singh, J. Moran, A.R. Rizkala, and R. Geronemus et al. Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin J Am Soc Nephrol 19 2008 372 379
78. T. Ganz Hepcidin and iron regulation, 10 years later Blood 117 2011 4425 4433
79. M.A. Pfeffer, E.A. Burdmann, C.Y. Chen, M.E. Cooper, D. de Zeeuw, and K.U. Eckardt et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2009 2019 2032
80. A.K. Singh, L. Szczech, K.L. Tang, H. Barnhart, S. Sapp, and M. Wolfson et al. Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 2006 2085 2098
81. FDA FDA modifies dosing recommendations for Erythropoiesis-Stimulating Agents Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm260670.htm [Accessed on 8 July, 2013]
82. C.C. Sun, V. Vaja, J.L. Babitt, and H.Y. Lin Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation Am J Hematol 87 2012 392 400
83. B.J. Sasu, K.S. Cooke, T.L. Arvedson, C. Plewa, A.R. Ellison, and J. Sheng et al. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia Blood 115 2010 3616 3624
84. J.J. Xiao, W. Krzyzanski, Y.M. Wang, H. Li, M.J. Rose, and M. Ma et al. Pharmacokinetics of anti-hepcidin monoclonal antibody Ab 12B9m and hepcidin in cynomolgus monkeys AAPS J 12 2010 646 657
85. Akin Akinc, Amy Chan-Daniels, Alfica Sehgal, Don Foster, Brian R. Bettencourt, and Julia Hettinger et al. Targeting the Hepcidin Pathway with RNAi Therapeutics for the Treatment of Anemia ASH Annual, Meeting Abstracts 2011 118
86. EUROCALIN EUROpean Consortium for AntiCALINS as next generation high-affinity protein therapeutics Available from: http://www.eurocalin-fp7.eu/ index.html 2011 [Accessed on 8 July, 2013]
87. Noxxon NOX-H94 Available from: http://www.noxxon.com/index.php?option= com-content&view=article&id=22&Itemid=479 2011 [Accessed on 8 July, 2013]
88. I. Theurl, A. Schroll, T. Sonnweber, M. Nairz, M. Theurl, and W. Willenbacher et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats Blood 118 2011 4977 4984
89. J.L. Babitt, F.W. Huang, Y. Xia, Y. Sidis, N.C. Andrews, and H.Y. Lin Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance J Clin Invest 117 2007 1933 1939
90. S.N. Song, N. Tomosugi, H. Kawabata, T. Ishikawa, T. Nishikawa, and K. Yoshizaki Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease Blood 116 2010 3627 3634
91. F. van Rhee, L. Fayad, P. Voorhees, R. Furman, S. Lonial, and H. Borghaei et al. Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease J Clin Oncol 28 2010 3701 3708
92. J.R. Caceres-Cortes A potent anti-carcinoma and anti-acute myeloblastic leukemia agent, AG490 Anticancer Agents Med Chem 8 2008 717 722
93. J. Bacchetta Vitamin D, as a new regulator of iron metabolism: vitamin D suppresses hepcidin in vitro and in vivo Nephrol Dial Transplant 27 2012 ii28 ii30
94. Leung DDM, Luan P, Menetta JV, Tang Y, Witcher D. Anti-Ferroportin 1 Monoclonal Antibodies and Uses Thereof., Patent # 7820163. Indianapolis, IN: Eli Lilly and Company; 2011.